158 related articles for article (PubMed ID: 9201666)
1. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
[TBL] [Abstract][Full Text] [Related]
2. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
Geller G; Doksum T; Bernhardt BA; Metz SA
Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
[TBL] [Abstract][Full Text] [Related]
3. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
Lerman C; Biesecker B; Benkendorf JL; Kerner J; Gomez-Caminero A; Hughes C; Reed MM
J Natl Cancer Inst; 1997 Jan; 89(2):148-57. PubMed ID: 8998184
[TBL] [Abstract][Full Text] [Related]
4. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
6. Perceptions of Ashkenazi Jewish breast cancer patients on genetic testing for mutations in BRCA1 and BRCA2.
Phillips KA; Warner E; Meschino WS; Hunter J; Abdolell M; Glendon G; Andrulis IL; Goodwin PJ
Clin Genet; 2000 May; 57(5):376-83. PubMed ID: 10852372
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review.
Pasacreta JV
Cancer Invest; 2003; 21(4):588-623. PubMed ID: 14533449
[TBL] [Abstract][Full Text] [Related]
8. Genetic Testing and Post-Testing Decision Making among BRCA-Positive Mutation Women: A Psychosocial Approach.
Hesse-Biber S; An C
J Genet Couns; 2016 Oct; 25(5):978-92. PubMed ID: 26758254
[TBL] [Abstract][Full Text] [Related]
9. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
10. Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Katapodi MC; Northouse LL; Milliron KJ; Liu G; Merajver SD
Psychooncology; 2013 Jun; 22(6):1336-43. PubMed ID: 22826208
[TBL] [Abstract][Full Text] [Related]
11. Experiences of BRCA1/2 Gene Mutation-Positive Women With Cancer in Communicating Genetic Risk to Their Relatives.
Seven M; Shah LL; Daack-Hirsch S; Yazici H
Cancer Nurs; 2021 May-Jun 01; 44(3):E142-E150. PubMed ID: 32022782
[TBL] [Abstract][Full Text] [Related]
12. "Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing.
Geller G; Strauss M; Bernhardt BA; Holtzman NA
Hastings Cent Rep; 1997; 27(2):28-33. PubMed ID: 9131350
[TBL] [Abstract][Full Text] [Related]
13. Decision-making about genetic testing among women at familial risk for breast cancer.
Jacobsen PB; Valdimarsdottier HB; Brown KL; Offit K
Psychosom Med; 1997; 59(5):459-66. PubMed ID: 9316177
[TBL] [Abstract][Full Text] [Related]
14. Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.
Bluman LG; Rimer BK; Regan Sterba K; Lancaster J; Clark S; Borstelmann N; Iglehart JD; Winer EP
Psychooncology; 2003; 12(5):410-27. PubMed ID: 12833555
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.
Rosenberg SM; Ruddy KJ; Tamimi RM; Gelber S; Schapira L; Come S; Borges VF; Larsen B; Garber JE; Partridge AH
JAMA Oncol; 2016 Jun; 2(6):730-6. PubMed ID: 26867710
[TBL] [Abstract][Full Text] [Related]
16. Application of the protection motivation theory to genetic testing for breast cancer risk.
Helmes AW
Prev Med; 2002 Nov; 35(5):453-62. PubMed ID: 12431894
[TBL] [Abstract][Full Text] [Related]
17. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
Wong XY; Chong KJ; van Til JA; Wee HL
BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
[TBL] [Abstract][Full Text] [Related]
18. Fertility intentions following testing for a BRCA1 gene mutation.
Smith KR; Ellington L; Chan AY; Croyle RT; Botkin JR
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):733-40. PubMed ID: 15159303
[TBL] [Abstract][Full Text] [Related]
19. Accommodating risk: responses to BRCA1/2 genetic testing of women who have had cancer.
Hallowell N; Foster C; Eeles R; Ardern-Jones A; Watson M
Soc Sci Med; 2004 Aug; 59(3):553-65. PubMed ID: 15144764
[TBL] [Abstract][Full Text] [Related]
20. Women's decision-making about their health care: views over the life cycle.
Brown JB; Carroll J; Boon H; Marmoreo J
Patient Educ Couns; 2002 Dec; 48(3):225-31. PubMed ID: 12477607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
